oxonic acid has been researched along with Cancer of Prostate in 4 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with histological proof of prostate cancer refractory to hormonal therapies were eligible." | 2.75 | Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study. ( Akaza, H; Fujimoto, H; Ikemoto, I; Kobayashi, M; Naito, S; Namiki, M; Tsukamoto, T; Usami, M, 2010) |
| "LNCaP cells, androgen dependent prostate cancer (ADPC) cells and C4-2 cells, which are a CRPC subline of LNCaP cells, were used." | 1.38 | Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer. ( Hasegawa, M; Ide, H; Kikuchi, E; Kosaka, T; Maeda, T; Miyajima, A; Oya, M; Shirotake, S; Tanaka, N; Yasumizu, Y, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaza, H | 2 |
| Ikemoto, I | 1 |
| Namiki, M | 1 |
| Usami, M | 1 |
| Kobayashi, M | 1 |
| Fujimoto, H | 1 |
| Tsukamoto, T | 1 |
| Naito, S | 1 |
| Hasegawa, M | 1 |
| Miyajima, A | 1 |
| Kosaka, T | 1 |
| Yasumizu, Y | 1 |
| Tanaka, N | 1 |
| Maeda, T | 1 |
| Shirotake, S | 1 |
| Ide, H | 1 |
| Kikuchi, E | 1 |
| Oya, M | 1 |
| Kume, H | 1 |
1 review available for oxonic acid and Cancer of Prostate
| Article | Year |
|---|---|
[The possibility of S-1 for the treatment of patients with urological cancers].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Clinical Trials, Phase II as Topic; Drug Adm | 2006 |
1 trial available for oxonic acid and Cancer of Prostate
| Article | Year |
|---|---|
Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study.
Topics: Adult; Aged; Alanine Transaminase; Androgen Antagonists; Anorexia; Antimetabolites, Antineoplastic; | 2010 |
2 other studies available for oxonic acid and Cancer of Prostate
| Article | Year |
|---|---|
Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Docetaxel; Drug Com | 2012 |
[Oral antineoplastic agents for prostate cancer].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combine | 2011 |